status of usage of olanzapine in patients with malignancies at our hospital
Not Applicable
- Conditions
- malignant tumor
- Registration Number
- JPRN-UMIN000044105
- Lead Sponsor
- Kanto Central Hospital of the Mutual Aid Association School of Teachers (Clinical Research Center)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
Those who were prescribed the drug to treat comorbidities unrelated to malignancy. Those who refused to participate in the study by opting out.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate of symptom relief with olanzapine for each symptom
- Secondary Outcome Measures
Name Time Method Duration of prescription, reason for stopping prescription, number of days alive or days to end of treatment after starting, side effects